CELLULARLINE SPA (CELL.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:CELL - IT0005244618 - Common Stock
2.615 EUR
+0.02 (+0.77%)
Taking everything into account, CELL scores 5 out of 10 in our fundamental rating. CELL was compared to 30 industry peers in the Technology Hardware, Storage & Peripherals industry. CELL has an excellent financial health rating, but there are some minor concerns on its profitability. CELL is valued quite cheap, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
CELL had positive earnings in the past year.
In the past year CELL had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: CELL reported negative net income in multiple years.
In the past 5 years CELL always reported a positive cash flow from operatings.
1.2 Ratios
CELL has a Return On Assets (2.60%) which is in line with its industry peers.
CELL has a better Return On Equity (4.27%) than 63.33% of its industry peers.
Looking at the Return On Invested Capital, with a value of 4.42%, CELL is in line with its industry, outperforming 50.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.6% | ||
| ROE | 4.27% | ||
| ROIC | 4.42% |
ROA(3y)-10.28%
ROA(5y)-5.5%
ROE(3y)-16.94%
ROE(5y)-9.21%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
CELL has a Profit Margin (3.44%) which is in line with its industry peers.
CELL's Profit Margin has declined in the last couple of years.
CELL has a better Operating Margin (4.91%) than 63.33% of its industry peers.
CELL's Operating Margin has declined in the last couple of years.
CELL has a better Gross Margin (40.07%) than 63.33% of its industry peers.
In the last couple of years the Gross Margin of CELL has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.91% | ||
| PM (TTM) | 3.44% | ||
| GM | 40.07% |
OM growth 3Y35.04%
OM growth 5Y-19.56%
PM growth 3YN/A
PM growth 5Y-23.32%
GM growth 3Y-2.78%
GM growth 5Y-2.73%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CELL is destroying value.
CELL has less shares outstanding than it did 1 year ago.
CELL has less shares outstanding than it did 5 years ago.
CELL has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.35 indicates that CELL is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of CELL (2.35) is comparable to the rest of the industry.
CELL has a debt to FCF ratio of 2.46. This is a good value and a sign of high solvency as CELL would need 2.46 years to pay back of all of its debts.
The Debt to FCF ratio of CELL (2.46) is better than 73.33% of its industry peers.
CELL has a Debt/Equity ratio of 0.13. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.13, CELL is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.13 | ||
| Debt/FCF | 2.46 | ||
| Altman-Z | 2.35 |
ROIC/WACC0.5
WACC8.85%
2.3 Liquidity
A Current Ratio of 2.12 indicates that CELL has no problem at all paying its short term obligations.
CELL has a Current ratio of 2.12. This is in the better half of the industry: CELL outperforms 66.67% of its industry peers.
CELL has a Quick Ratio of 1.33. This is a normal value and indicates that CELL is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.33, CELL is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.12 | ||
| Quick Ratio | 1.33 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 60.78% over the past year.
Measured over the past years, CELL shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -20.43% on average per year.
The Revenue has been growing slightly by 3.54% in the past year.
Measured over the past years, CELL shows a small growth in Revenue. The Revenue has been growing by 3.18% on average per year.
EPS 1Y (TTM)60.78%
EPS 3YN/A
EPS 5Y-20.43%
EPS Q2Q%-4.76%
Revenue 1Y (TTM)3.54%
Revenue growth 3Y14.1%
Revenue growth 5Y3.18%
Sales Q2Q%-2.91%
3.2 Future
CELL is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.47% yearly.
The Revenue is expected to decrease by -0.60% on average over the next years.
EPS Next Y-15%
EPS Next 2Y2.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-6.17%
Revenue Next 2Y-0.6%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 10.06, which indicates a very decent valuation of CELL.
CELL's Price/Earnings ratio is rather cheap when compared to the industry. CELL is cheaper than 86.67% of the companies in the same industry.
CELL's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.00.
A Price/Forward Earnings ratio of 6.10 indicates a rather cheap valuation of CELL.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CELL indicates a rather cheap valuation: CELL is cheaper than 100.00% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of CELL to the average of the S&P500 Index (23.70), we can say CELL is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.06 | ||
| Fwd PE | 6.1 |
4.2 Price Multiples
CELL's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CELL is cheaper than 93.33% of the companies in the same industry.
CELL's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CELL is cheaper than 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 3.83 | ||
| EV/EBITDA | 3.04 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y2.47%
EPS Next 3YN/A
5. Dividend
5.1 Amount
CELL has a Yearly Dividend Yield of 3.60%. Purely for dividend investing, there may be better candidates out there.
CELL's Dividend Yield is rather good when compared to the industry average which is at 1.04. CELL pays more dividend than 90.00% of the companies in the same industry.
CELL's Dividend Yield is rather good when compared to the S&P500 average which is at 1.94.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.6% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
CELL pays out 34.37% of its income as dividend. This is a sustainable payout ratio.
DP34.37%
EPS Next 2Y2.47%
EPS Next 3YN/A
BIT:CELL (1/5/2026, 5:29:46 PM)
2.615
+0.02 (+0.77%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryTechnology Hardware, Storage & Peripherals
Earnings (Last)
Earnings (Next)
Inst Owners4.94%
Inst Owner ChangeN/A
Ins Owners19.57%
Ins Owner ChangeN/A
Market Cap57.19M
Revenue(TTM)164.26M
Net Income(TTM)5.65M
Analysts82.86
Price Target4.18 (59.85%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.6% |
Yearly Dividend0.08
Dividend Growth(5Y)N/A
DP34.37%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-2.86%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.51%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.06 | ||
| Fwd PE | 6.1 | ||
| P/S | 0.35 | ||
| P/FCF | 3.83 | ||
| P/OCF | 2.82 | ||
| P/B | 0.43 | ||
| P/tB | 1.05 | ||
| EV/EBITDA | 3.04 |
EPS(TTM)0.26
EY9.94%
EPS(NY)0.43
Fwd EY16.38%
FCF(TTM)0.68
FCFY26.08%
OCF(TTM)0.93
OCFY35.49%
SpS7.51
BVpS6.05
TBVpS2.49
PEG (NY)N/A
PEG (5Y)N/A
Graham Number5.95
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.6% | ||
| ROE | 4.27% | ||
| ROCE | 5.04% | ||
| ROIC | 4.42% | ||
| ROICexc | 5.33% | ||
| ROICexgc | 12.93% | ||
| OM | 4.91% | ||
| PM (TTM) | 3.44% | ||
| GM | 40.07% | ||
| FCFM | 9.08% |
ROA(3y)-10.28%
ROA(5y)-5.5%
ROE(3y)-16.94%
ROE(5y)-9.21%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y46.34%
ROICexgc growth 5Y-17.53%
ROICexc growth 3Y77.77%
ROICexc growth 5Y-8.95%
OM growth 3Y35.04%
OM growth 5Y-19.56%
PM growth 3YN/A
PM growth 5Y-23.32%
GM growth 3Y-2.78%
GM growth 5Y-2.73%
F-Score4
Asset Turnover0.76
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.13 | ||
| Debt/FCF | 2.46 | ||
| Debt/EBITDA | 0.81 | ||
| Cap/Depr | 39.19% | ||
| Cap/Sales | 3.28% | ||
| Interest Coverage | 2.77 | ||
| Cash Conversion | 93.13% | ||
| Profit Quality | 264.18% | ||
| Current Ratio | 2.12 | ||
| Quick Ratio | 1.33 | ||
| Altman-Z | 2.35 |
F-Score4
WACC8.85%
ROIC/WACC0.5
Cap/Depr(3y)26.8%
Cap/Depr(5y)35.01%
Cap/Sales(3y)3.22%
Cap/Sales(5y)4.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)60.78%
EPS 3YN/A
EPS 5Y-20.43%
EPS Q2Q%-4.76%
EPS Next Y-15%
EPS Next 2Y2.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)3.54%
Revenue growth 3Y14.1%
Revenue growth 5Y3.18%
Sales Q2Q%-2.91%
Revenue Next Year-6.17%
Revenue Next 2Y-0.6%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y59.25%
EBIT growth 3Y54.08%
EBIT growth 5Y-17%
EBIT Next Year25.99%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y1050.19%
FCF growth 3Y4.84%
FCF growth 5Y6.28%
OCF growth 1Y730.91%
OCF growth 3Y4.12%
OCF growth 5Y1.2%
CELLULARLINE SPA / CELL.MI FAQ
What is the ChartMill fundamental rating of CELLULARLINE SPA (CELL.MI) stock?
ChartMill assigns a fundamental rating of 5 / 10 to CELL.MI.
What is the valuation status for CELL stock?
ChartMill assigns a valuation rating of 7 / 10 to CELLULARLINE SPA (CELL.MI). This can be considered as Undervalued.
What is the profitability of CELL stock?
CELLULARLINE SPA (CELL.MI) has a profitability rating of 4 / 10.
What are the PE and PB ratios of CELLULARLINE SPA (CELL.MI) stock?
The Price/Earnings (PE) ratio for CELLULARLINE SPA (CELL.MI) is 10.06 and the Price/Book (PB) ratio is 0.43.
Can you provide the dividend sustainability for CELL stock?
The dividend rating of CELLULARLINE SPA (CELL.MI) is 6 / 10 and the dividend payout ratio is 34.37%.